The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
FICO, EHang, and Caris Life Sciences announced major share repurchase programs to enhance shareholder value. FICO (Fair Isaac Corporation) increased its authorization to $2 billion, securing a $1.5 billion term loan to fund an accelerated stock repurchase agreement. Meanwhile, EHang launched a $30 million program, and Caris Life Sciences authorized the buyback of up to $100 million of its common stock.